Estradiol modulates breast cancer cell apoptosis: A novel nongenomic steroid action relevant to carcinogenesis

Steroids

Volumn 64, Issue 1-2, 1999, Pages 22-27

  Tesarik, Jan ^a   Garrigosa, Loreto ^b   Mendoza, Carmen ^b  

^a LABORATOIRE D EYLAU   (France)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Apoptosis; Breast cancer cells; Carcinogenesis; Estrogen; Nongenomic steroid effects

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; BOVINE SERUM ALBUMIN; ESTRADIOL; ESTRADIOL RECEPTOR; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROPIDIUM IODIDE;

APOPTOSIS; BREAST CARCINOGENESIS; CELL SELECTION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONFERENCE PAPER; HORMONE PROTEIN COMPLEX; HORMONE RECEPTOR INTERACTION; HUMAN; MOLECULAR DYNAMICS; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

APOPTOSIS; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; ENZYME ACTIVATION; ESTRADIOL; HUMANS; PROTEIN-TYROSINE KINASES; TRANSCRIPTION FACTOR AP-1; TUMOR CELLS, CULTURED; VITAMIN E;

BOVINAE;

EID: 0032945889     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(98)00106-8     Document Type: Conference Paper

References (45)

1. Sica V., Nola E., Contieri E., Bova R., Masucci M.T., Medici N., Petrillo A., Weisz A., Molinari A.M., Puca G.A. Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res. 44:1984;4670-4674.
2. Auricchio F., Di Domenico M., Migliaccio A., Castoria G., Bilancio A. The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells. Cell Growth Differ. 6:1995;105-113.
3. Di Domenico M, Castoria G, Bilancio A, Migliaccio A, Auricchio F. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res 56:4516-21.
4. Watters J.J., Campbell J.S., Cunningham M.J., Krebs E.G., Dorsa D.M. Rapid membrane effects of steroids in neuroblastoma cells effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription . Endocrinology. 138:1997;4030-4033.
5. Migliaccio A., Pagano M., Auricchio F. Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. Oncogene. 8:1993;2183-2191.
6. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 262:1987;5592-5595.
7. Murkies A.L., Wilcox G., Davis S. Phytoestrogens. J Clin Endocrinol Metab. 83:1998;297-303.
8. Tesarik J., Mendoza C. Phyto-oestrogens and breast cancer. Lancet. 351:1998;138.
9. Ingram D., Sanders K., Kolybaba M., Lopez D. Case-control study of phyto-estrogens and breast cancer. Lancet. 350:1997;990-994.
10. El Yazidi I., Renaud F., Laurent M., Courtois Y., Boilly Marer Y. Production and oestrogen regulation of FGF1 in normal and cancer breast cells. Biochim Biophys Acta. 1403:1998;127-140.
11. Musgrove E.A., Lee C.S., Buckley M.F., Sutherland R.L. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci USA. 91:1994;8022-8026.
12. Planas-Silva M.D., Weinberg R.A. Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution. Mol Cell Biol. 17:1997;4059-4069.
13. Prall O.W.J., Sarcevic B., Musgrove E.A., Watts C.K.W., Sutherland R.L. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J Biol Chem. 272:1997;10882-10894.
14. Weisz A., Bresciani F. Estrogen regulation of proto-oncogenes coding for nuclear proteins. Crit Rev Oncog. 4:1993;361-388.
15. Alvarez R.J. Jr, Gips S.J., Moldovan N., Wilhide C.C., Milliken E.E., Hoang A.T., Hruban R.H., Silverman H.S., Dang C.V., Goldschmidt-Clermont P.J. 17β-Estradiol inhibits apoptosis of endothelial cells. Biochem Biophys Res Commun. 237:1997;372-381.
16. Hashimoto M., Inoue S., Muramatsu M., Masliah E. Estrogens stimulate tamoxifen-induced neuronal cell apoptosis in vitro a possible nongenomic action . Biochem Biophys Res Commun. 240:1997;464-470.
17. Olsen N.J., Viselli S.M., Fan J., Kovacs W.J. Androgens accelerate thymocyte apoptosis. Endocrinology. 139:1998;748-752.
18. Tesarik J., Mendoza C., Moos J., Fénichel P., Fehlmann M. Progesterone action through aggregation of a receptor on the sperm plasma membrane. FEBS Lett. 308:1992;116-120.
19. Tesarik J., Mendoza C. Insights into the function of a sperm-surface progesterone receptor evidence of ligand-induced receptor aggregation and the implication of proteolysis . Exp Cell Res. 205:1993;111-117.
20. Tesarik J., Moos J., Mendoza C. Stimulation of protein tyrosine phosphorylation by a progesterone receptor on the cell surface of human sperm. Endocrinology. 133:1993;328-335.
21. Neulen J., Ishikawa K., Blackmore P.F., Beebe S.T. Identification and characterization of progesterone binding proteins in human semen. Endocr J. 1:1993;397-404.
22. Luconi M., Bonaccorsi L., Maggi M., Pecchioli P., Krausz C., Forti G., Baldi E. Identification and characterization of functional nongenomic progesterone receptors on human sperm membrane. J Clin Endocrinol Metab. 83:1998;877-885.
23. Sabeur K., Edwards D.P., Meizel S. Human sperm plasma membrane progesterone receptor(s) and the acrosome reaction. Biol Reprod. 54:1996;993-1001.
24. Blackmore P.F., Beebe S.J., Danforth D.R., Alexander N. Progesterone and 17α-hydroxyprogesterone. Novel stimulators of calcium influx in human sperm. J Biol Chem. 265:1990;1376-1380.
25. Yang J., Serres C., Philibert D., Robel P., Baulieu E.E., Jouannet P. Progesterone and RU486 Opposing effects on human sperm . Proc Natl Acad Sci USA. 91:1994;529-533.
26. Migliaccio A., Di Domenico M., Castoria G., de Falco A., Bontempo P., Nola E., Auricchio F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1996;1292-1300.
27. Matsuda S., Kadowaki Y., Ichino M., Akiyama T., Toyoshima K., Yamamoto T. 17β-Estradiol mimics ligand activity of the c-erb B2 proto-oncogene product. Proc Natl Acad Sci USA. 90:1993;10803-10807.
28. Rosen N., Bolen J.B., Schwartz A.M., Cohen P., De Seau V., Israel M.A. Analysis of pp60 c-src protein kinase activity in human tumor cell line and tissues. J Biol Chem. 261:1986;13754-13759.
29. Ottenhoff-Klaff A.E., Rijksen G., van Beurden E.A.C.M., Hennipman A., Michels A.A., Staal G.E.J. Characterization of protein tyrosine kinases from human breast cancer involvement of the c-src oncogene product . Cancer Res. 52:1992;4773-4778.
30. Egan S.E., Giddings B.W., Brooks M.W., Buday L., Sizeland A.M., Weinberg R. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature. 363:1993;45-51.
31. Endoh H., Sasaki H., Maruyama K., Takeyama K., Waga I., Shimizu T., Kato S., Kawashima H. Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem Biophys Res Commun. 235:1997;99-102.
32. Morte C., Iborra A., Martinez P. Phosphorylation of Shc proteins in human sperm in response to capacitation and progesterone treatment. Mol Reprod Dev. 50:1998;113-120.
33. Luconi M., Krausz C., Barni T., Vannelli G.B., Forti G., Baldi E. Progesterone stimulates p42 extracellular-signal regulated kinase (p42ERK) in human spermatozoa. Mol Hum Reprod. 4:1998;251-258.
34. Migliaccio A., Piccolo D., Castoria G., Di Domenico M., Bilancio A., Lombardi M., Gong W., Beato M., Auricchio F. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J. 17:1998;2008-2018.
35. Derijard B., Hibi M., Wu I.H., Barret T., Su B., Deng T.L., Karin M., Davis R.J. Jnk A protein kinase stimulated by UV light and HA-Ras that binds and phosphorylates the c-Jun activation domain . Cell. 76:1994;1025-1037.
36. Colotta F., Polentarutti N., Sironi M., Mantovani A. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J Biol Chem. 267:1992;18248-18283.
37. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
38. van Dam H., Wilhelm D., Herr I., Steffen A., Herrlich P., Angel P. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14:1995;1798-1811.
39. Verheij M., Bose R., Lin X.H. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 380:1996;75-79.
40. Chen Y.-R., Wang X., Templeton D., Davis R.J., Tan T-H. The role of c-jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. J Biol Chem. 271:1996;31929-31936.
41. Ham J., Babij C., Whitfield J. A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron. 14:1995;927-939.
42. Bossy-Wetzel E., Bakiri L., Yaniv M. Induction of apoptosis by the transcription factor c-jun. EMBO J. 16:1997;1695-1709.
43. Zhao B., Yu W., Qian M., Simmons-Menchaca M., Brown P., Birrer M.J., Sanders B.G., Kline K. Involvement of activator protein-1 (AP-1) in induction of apoptosis by vitamin E succinate in human breast cancer cells. Mol Carcinog. 19:1997;180-190.
44. Qian M., Sanders B.G., Kline K. RRR-α-tocopheryl succinate induces apoptosis in avian retrovirus-transformed lymphoid cells. Nutr Cancer. 25:1996;9-26.
45. van Engeland M., Kuijpers H.J.H., Ramaekers F.C.S. Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp Cell Res. 235:1997;421-430.